全文获取类型
收费全文 | 73532篇 |
免费 | 5723篇 |
国内免费 | 214篇 |
学科分类
医药卫生 | 79469篇 |
出版年
2023年 | 539篇 |
2022年 | 903篇 |
2021年 | 2123篇 |
2020年 | 1305篇 |
2019年 | 1944篇 |
2018年 | 2349篇 |
2017年 | 1677篇 |
2016年 | 1747篇 |
2015年 | 2010篇 |
2014年 | 2909篇 |
2013年 | 3655篇 |
2012年 | 5654篇 |
2011年 | 5850篇 |
2010年 | 3170篇 |
2009年 | 2877篇 |
2008年 | 4737篇 |
2007年 | 4883篇 |
2006年 | 4669篇 |
2005年 | 4490篇 |
2004年 | 4017篇 |
2003年 | 3830篇 |
2002年 | 3411篇 |
2001年 | 774篇 |
2000年 | 675篇 |
1999年 | 684篇 |
1998年 | 730篇 |
1997年 | 592篇 |
1996年 | 463篇 |
1995年 | 427篇 |
1994年 | 368篇 |
1993年 | 344篇 |
1992年 | 407篇 |
1991年 | 367篇 |
1990年 | 342篇 |
1989年 | 319篇 |
1988年 | 337篇 |
1987年 | 294篇 |
1986年 | 292篇 |
1985年 | 246篇 |
1984年 | 242篇 |
1983年 | 229篇 |
1982年 | 210篇 |
1981年 | 186篇 |
1980年 | 198篇 |
1979年 | 187篇 |
1978年 | 168篇 |
1977年 | 129篇 |
1976年 | 128篇 |
1974年 | 149篇 |
1973年 | 122篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Size at birth and carotid atherosclerosis in later life 总被引:4,自引:0,他引:4
Several studies have shown that low birthweight is associated with a higher risk of stroke and coronary heart disease in later life. Increased atherogenesis may be one underlying mechanism, but few studies have examined this directly. We used duplex ultrasonography to assess the extra-cranial carotid arteries of 389 elderly men and women born and still living in Sheffield, UK, whose recorded birth measurements were available. Men and women who had weighed 6.5 lbs or less at birth had a higher risk of having carotid stenosis >30% than those who weighed over 7.5 lbs, but this trend was not statistically significant (OR 1.8, 95% CI 1.0-3.3). Women who had been lighter or who had a smaller head circumference at birth tended to have an increased intima-media thickness, but these relations ceased to be statistically significant after adjustment for gestational age and cardiovascular risk factors. In men, by contrast, an increased intima-media thickness was associated with having been heavier at birth (P=0.049) or having had a larger abdominal circumference at birth (P=0.040), after adjustment for gestational age and cardiovascular risk factors. These results provide little evidence that impaired fetal growth increases susceptibility to atherogenesis. 相似文献
992.
Additive effects of simulated climate changes,elevated CO2, and nitrogen deposition on grassland diversity 总被引:7,自引:0,他引:7 下载免费PDF全文
Zavaleta ES Shaw MR Chiariello NR Mooney HA Field CB 《Proceedings of the National Academy of Sciences of the United States of America》2003,100(13):7650-7654
Biodiversity responses to ongoing climate and atmospheric changes will affect both ecosystem processes and the delivery of ecosystem goods and services. Combined effects of co-occurring global changes on diversity, however, are poorly understood. We examined plant diversity responses in a California annual grassland to manipulations of four global environmental changes, singly and in combination: elevated CO2, warming, precipitation, and nitrogen deposition. After 3 years, elevated CO2 and nitrogen deposition each reduced plant diversity, whereas elevated precipitation increased it and warming had no significant effect. Diversity responses to both single and combined global change treatments were driven overwhelmingly by gains and losses of forb species, which make up most of the native plant diversity in California grasslands. Diversity responses across treatments also showed no consistent relationship to net primary production responses, illustrating that the diversity effects of these environmental changes could not be explained simply by changes in productivity. In two- to four-way combinations, simulated global changes did not interact in any of their effects on diversity. Our results show that climate and atmospheric changes can rapidly alter biological diversity, with combined effects that, at least in some settings, are simple, additive combinations of single-factor effects. 相似文献
993.
Gibson CM Karha J Murphy SA James D Morrow DA Cannon CP Giugliano RP Antman EM Braunwald E;TIMI Study Group 《Journal of the American College of Cardiology》2003,42(1):7-16
OBJECTIVES: We hypothesized that early recurrent myocardial infarction (MI) following fibrinolytic administration would be assessed with higher mortality at both 30 days and 2 years. BACKGROUND: Although early recurrent MI after fibrinolytic therapy has been associated with increased early mortality in the acute MI setting, its relation to long-term mortality has not been fully explored. METHODS: Mortality data were ascertained in 20,101 patients enrolled in the Thrombolysis In Myocardial Infarction (TIMI) 4, 9, and 10B and Intravenous NPA for the Treatment of Infarcting Myocardium Early (InTIME-II) acute MI trials. RESULTS: The frequency of symptomatic recurrent MI during the index hospitalization was 4.2% (836/20,101). Recurrent MI during the index hospital period was associated with increased 30-day mortality (16.4% [137/836] vs. 6.2% [1,188/19,260], p < 0.001). Likewise, recurrent MI was associated with a sustained increase in mortality up to two years, even after adjustments were made for covariates known to be associated with mortality and recurrent MI (hazard ratio 2.11, p < 0.001). However, this higher mortality at 2 years was due to an early divergence in mortality by 30 days and was not due to a significant increase in late mortality between 30 days and 2 years (4.38% [31/707] vs. 3.76% [685/18,206], p = NS). Percutaneous coronary intervention during the index hospitalization was associated with a lower rate of in-hospital recurrent MI (1.6% vs. 4.5%, p < 0.001) and lower two-year mortality (5.6% vs. 11.6%, p < 0.001). Performance of coronary artery bypass graft surgery was also associated with a lower recurrent rate of MI (0.7% vs. 4.3%, p < 0.001) and lower two-year mortality rate (7.95% vs. 10.6%, p = 0.0008). CONCLUSIONS: Early recurrent MI is associated with increased mortality up to two years. However, most deaths occur early, and the risk of additional deaths between the index hospital period and two years was not significantly increased among patients with recurrent MI. Percutaneous coronary intervention during the index hospitalization was associated with a lower risk of recurrent MI and a lower risk of two-year mortality. 相似文献
994.
Cannon CP 《Seminars in vascular medicine》2003,3(4):425-432
Although numerous clinical trials have identified many advances in the treatment of patients with acute coronary syndromes (ACS), registries of clinical practice have identified that in clinical practice a large proportion of patients do not receive guideline-recommended therapies. In addition to development and dissemination of national guidelines, there is a need for specific tools to ensure that the guideline recommendations are implemented on a patient-by-patient basis. Better adherence to practice guidelines has been found to be associated with improved outcomes. Critical pathways and/or the process of Continuous Quality Improvement (CQI) are means of trying to improve care. Critical pathways are standardized protocols that aim to optimize and streamline patient care, which usually involve standardized order sets, (or computerized ones), and/or simple pocket cards, reminders, or checklists of the appropriate therapies. Another key part of an overall CQI effort is to monitor data on performance-i.e. utilization of guideline recommended therapies. Several well-conducted studies, showing that particular use of critical pathways, can lead to improve quality of care. 相似文献
995.
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age 总被引:3,自引:0,他引:3
Price JF Kertesz NJ Snyder CS Friedman RA Fenrich AL 《Journal of the American College of Cardiology》2002,39(3):517-520
OBJECTIVES: The goal of this study was to assess the efficacy and safety of the combination therapy of flecainide and sotalol for the treatment of refractory supraventricular tachycardia (SVT) in children <1 year of age. BACKGROUND: Supraventricular tachycardia in infants can be refractory to single-drug as well as standard combination medical therapy. Radiofrequency ablation (RFA) is the definitive treatment of refractory SVT; however, interventional therapy poses a high risk of morbidity and mortality in this age group. METHODS: A retrospective review was performed identifying infants who required flecainide and sotalol to control refractory SVT. Patient age, previous drug therapy, duration of treatment, flecainide levels and corrected QT intervals were recorded; 24 h Holter monitoring was utilized to gauge efficacy of treatment. Efficacy was defined as suppression of SVT to no more than rare nonsustained episodes or slowing of SVT to a clinically tolerable rate. RESULTS: Ten patients (median age: 29 days, range: 1 to 241 days) failed at least two antiarrhythmic agents including either flecainide or sotalol as single agents before initiating combination therapy. Efficacy was achieved in all patients. The failure rate for therapy was reduced from 100% to 0% (95% confidence interval: 0% to 26%). The median doses used were: flecainide 100 mg/m(2)/day (range: 40 to 150 mg/m(2)/day) and sotalol 175 mg/m(2)/day (range: 100 to 250 mg/m(2)/day). Median duration of therapy was 16 months (range: 5 to 35 months). No proarrhythmia occurred. CONCLUSIONS: The combination of flecainide and sotalol can safely and effectively control refractory SVT and may obviate the need for RFA in children <1 year. 相似文献
996.
997.
998.
999.
Induced sputum inflammatory mediator concentrations in chronic cough 总被引:13,自引:0,他引:13
Birring SS Parker D Brightling CE Bradding P Wardlaw AJ Pavord ID 《American journal of respiratory and critical care medicine》2004,169(1):15-19
Previous studies have shown evidence of airway inflammation in patients with chronic cough and have suggested that the cough may be due to release of tussive mediators and activation of afferent sensory nerve endings. We measured the concentration of various proinflammatory and tussive mediators in induced sputum supernatants from 20 patients with cough variant asthma or eosinophilic bronchitis, 20 patients with nonasthmatic chronic cough, 22 patients with idiopathic chronic cough, and 18 healthy control subjects. We measured histamine, cysteinyl-leukotrienes, prostanoids (prostaglandin D2 and prostaglandin E2), and interleukin-8 by enzyme immunoassay. The median sputum histamine concentrations were significantly higher in patients with idiopathic chronic cough (8.0 ng/ml) and cough variant asthma/eosinophilic bronchitis (10.2 ng/ml) than in normal subjects (2.6 ng/ml; 95% confidence interval of difference from idiopathic chronic cough, 0.8 to 25.8 [p = 0.009] and 95% confidence interval of difference from cough variant asthma/eosinophilic bronchitis, 1.1 to 20.1 [p = 0.01]). Median sputum prostaglandin D2 and prostaglandin E2 concentrations were significantly higher in all categories of chronic cough. Our findings support the view that there is release of inflammatory and tussive mediators in patients with chronic cough and suggest that there might be similarities in the mechanism of cough in a diverse range of conditions. 相似文献
1000.